ECVOCY Trademark

Trademark Overview

On Friday, April 22, 2022, a trademark application was filed for ECVOCY with the United States Patent and Trademark Office. The USPTO has given the ECVOCY trademark a serial number of 97377330. The federal status of this trademark filing is REGISTERED as of Tuesday, April 8, 2025. This trademark is owned by Global Blood Therapeutics, Inc.. The ECVOCY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
ecvocy

General Information

Serial Number97377330
Word MarkECVOCY
Filing DateFriday, April 22, 2022
Status700 - REGISTERED
Status DateTuesday, April 8, 2025
Registration Number7755064
Registration DateTuesday, April 8, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of vaso-occlusive crisis; pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 28, 2022
Primary Code005
First Use Anywhere DateFriday, November 15, 2024
First Use In Commerce DateFriday, November 15, 2024

Trademark Owner History

Party NameGlobal Blood Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, April 26, 2022NEW APPLICATION ENTERED
Thursday, April 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 17, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 17, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 9, 2023ASSIGNED TO EXAMINER
Friday, February 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 5, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 5, 2023SOU EXTENSION 1 FILED
Thursday, October 5, 2023SOU EXTENSION 1 GRANTED
Saturday, October 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 24, 2024SOU EXTENSION 2 FILED
Wednesday, April 24, 2024SOU EXTENSION 2 GRANTED
Wednesday, October 16, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2024SOU EXTENSION 3 FILED
Wednesday, October 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2024SOU EXTENSION 3 GRANTED
Wednesday, December 11, 2024USE AMENDMENT FILED
Wednesday, December 11, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, February 22, 2025STATEMENT OF USE PROCESSING COMPLETE
Saturday, February 22, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 17, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, March 17, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 8, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, April 8, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

ecvocy pharmaceutical treatment preparations cell disease hypoxemic conditions sickle hypoxic disorders